Lineage Cell Therapeutics, Inc. (LCTX)
NYSEAMERICAN: LCTX · Real-Time Price · USD
0.504
-0.096 (-16.02%)
At close: Nov 22, 2024, 4:00 PM
0.520
+0.016 (3.20%)
After-hours: Nov 22, 2024, 7:59 PM EST

Lineage Cell Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Revenue
8.728.9514.74.341.833.52
Upgrade
Revenue Growth (YoY)
-0.60%-39.16%238.70%137.73%-48.05%-29.53%
Upgrade
Cost of Revenue
-2.310.670.731.430.390.41
Upgrade
Gross Profit
11.038.2713.982.921.443.1
Upgrade
Selling, General & Admin
14.5313.7722.5118.2115.5718.93
Upgrade
Research & Development
15.7115.7113.9933.9112.3217.95
Upgrade
Operating Expenses
30.2329.4836.552.1327.8936.88
Upgrade
Operating Income
-19.2-21.2-22.52-49.21-26.45-33.78
Upgrade
Interest & Investment Income
1.731.630.8301.041.51
Upgrade
Currency Exchange Gain (Loss)
1.01-0.5-21.492.882.53
Upgrade
Other Non Operating Income (Expenses)
-0.03-00.070.21-0.170.78
Upgrade
EBT Excluding Unusual Items
-16.49-20.08-23.62-47.52-22.7-28.95
Upgrade
Merger & Restructuring Charges
------5.1
Upgrade
Gain (Loss) on Sale of Investments
-0.03-0.18-2.193.730.7814.81
Upgrade
Legal Settlements
-3.53-3.53----
Upgrade
Other Unusual Items
-0.5-0.52--
Upgrade
Pretax Income
-20.05-23.28-25.81-43.27-21.92-19.23
Upgrade
Income Tax Expense
--1.80.54--1.24-7.41
Upgrade
Earnings From Continuing Operations
-20.05-21.48-26.35-43.27-20.69-11.83
Upgrade
Minority Interest in Earnings
-0.07-0.010.080.250.040.12
Upgrade
Net Income
-20.11-21.49-26.27-43.02-20.65-11.71
Upgrade
Net Income to Common
-20.11-21.49-26.27-43.02-20.65-11.71
Upgrade
Shares Outstanding (Basic)
184173170165150146
Upgrade
Shares Outstanding (Diluted)
184173170165150146
Upgrade
Shares Change (YoY)
7.29%1.69%3.22%9.64%3.10%14.68%
Upgrade
EPS (Basic)
-0.11-0.12-0.15-0.26-0.14-0.08
Upgrade
EPS (Diluted)
-0.11-0.12-0.15-0.26-0.14-0.08
Upgrade
Free Cash Flow
-23.06-29.240.65-23.9-19.82-32.39
Upgrade
Free Cash Flow Per Share
-0.13-0.170.00-0.15-0.13-0.22
Upgrade
Gross Margin
126.54%92.50%95.05%67.15%78.92%88.28%
Upgrade
Operating Margin
-220.21%-237.04%-153.17%-1133.63%-1448.36%-960.91%
Upgrade
Profit Margin
-230.66%-240.20%-178.69%-990.99%-1130.83%-333.12%
Upgrade
Free Cash Flow Margin
-264.43%-326.89%4.39%-550.59%-1085.27%-921.39%
Upgrade
EBITDA
-18.57-20.51-21.79-48.34-24.41-30.78
Upgrade
EBITDA Margin
-212.95%-229.30%-148.22%---
Upgrade
D&A For EBITDA
0.630.690.730.872.043
Upgrade
EBIT
-19.2-21.2-22.52-49.21-26.45-33.78
Upgrade
EBIT Margin
-220.21%-237.04%-153.17%---
Upgrade
Revenue as Reported
8.728.9514.74.341.833.52
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.